Table 2.
Variablesb | Type 2 diabetes (T2D) |
Multivariate logistic regression analysisc |
||||
---|---|---|---|---|---|---|
No (n = 11,506) |
Yes (n = 682) |
|||||
na | na | OR | 95% CI | |||
Non-European ethnicity | 2368 | 182 | 3·48 | 2·83–4·28 | ||
Family history of T2D | 2150 | 298 | 2·57 | 2·16–3·06 | ||
22q11.2 microdeletiond | 289 | 25 | 2·44 | 1·39–4·31 | ||
Antipsychotic use | 231 | 32 | 1·78 | 1·09–2·92 | ||
Male sex | 5671 | 362 | 1·51 | 1·28–1·80 | ||
Mean | SD | Mean | SD | |||
Age (years) | 41·2 | 14·4 | 55·8 | 9·4 | 2·59 | 2·39–2·82 |
Body mass index | 26·8 | 5·5 | 32·0 | 7·2 | 1·90 | 1·77–2·03 |
OR = Odds ratio; CI = Confidence interval; SD = Standard deviation.
Survey weights used to obtain population estimates for analyses were based on originating samples involving n = 12,188 participants (n = 11,874 from a Canadian population sample; n = 314 with 22q11.2 deletion syndrome); see Methods for details.
Definitions for variables are outlined in Methods. Continuous variables, age and body mass index (BMI; used as a proxy for obesity), were analysed using increments of 10 and 5, respectively.
Likelihood ratio for model: χ2 = 1317·65, df = 7, p <0·0001; significant results are in bold font.
Ascertained through specialty clinic for adults with 22q11.2 deletion syndrome (n = 314); data on 22q11.2 deletion status for the population-based sample (estimated n = 0–3) unavailable; see Methods for details.